Allarity Therapeutics Inc Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.35M To $3.2M
Portfolio Pulse from Benzinga Newsdesk
Allarity Therapeutics Inc has filed a prospectus supplement with the SEC to increase the offering price of its common stock from $2.35 million to $3.2 million.
April 12, 2024 | 6:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allarity Therapeutics Inc plans to increase its common stock offering price from $2.35 million to $3.2 million.
Increasing the offering price of its common stock could indicate a positive outlook from the company or a response to investor demand, potentially leading to a positive short-term impact on the stock price. However, the actual impact could vary depending on market conditions and investor perception.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100